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ABSTRACT 
Spermatozoa survivability is of utmost importance in delivering equine semen for 
artificial insemination. Semen extender supplementation may allow for increased 
survivability. L-carnitine (CARN) has been studied for its role in the mobilization of fatty 
acids. Two experiments (EX1/EX2) assessed the effects of CARN and pyruvate (P) on 
spermatozoa survival. Total (TM) and progressive motility (PM), velocity and direction 
of movement (VAP, VSL, VCL, and elongation) were assessed by CASA, membrane 
status (SYBR 14/PI stains) and acrosome status (FITC-PSA stain) by flow cytometer. In 
EX1, 4 ejaculates were collected from 2 stallions. Aliquots were diluted in skim-milk 
glucose extender (SKMG) or INRA 96 (INRA) with and without CARN and P added at 
levels of 0.00806 g/mL and 0.0011004 g/mL. Split aliquots were placed in separate 
Equine Express II™ containers for CASA after 2 hours, 24 hours, and 48 hours. Flow 
cytometery was conducted at 24 hours. In EX 2, 4 ejaculates were collected from 3 
stallions. Aliquots were diluted in SKMG, INRA, and Revolution (REV) with or without 
CARN+P. In EX1/EX2 dilution in INRA resulted in higher motility compared to dilution 
in other extenders (p<0.05). In EX1 CARN+P (p<0.01) improved TM and PM. Intact 
membrane percentages were higher (p<0.05) for with CARN + P (74.3% with vs. 71.7% 
without). In EX2 CARN+P (p<0.05) improved TM and PM and also improved (p<0.05) 
percentage of intact membranes (78.0% with vs. 75.0% without) and intact acrosomes 
(78.9% with vs. 66.2% without).  In conclusion, addition of L-carnitine + pyruvate may 
improve multiple factors of spermatozoa survival. 
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1 
INTRODUCTION 
 
Justification 
In the field of equine fertility and reproduction, overall survival of spermatozoa 
after suspension in extender is of utmost importance and concern in the effectiveness of 
providing viable and motile semen for artificial insemination. A majority of infertility 
issues within the male sex of a species are related to spermatozoa malfunction (Sikka, 
1996.).     
Processing techniques have profound impact on semen characteristics. Some of 
these processes include cooling, freezing, dilution, and the process of centrifugation to 
remove the seminal plasma.  
Different compounds have been tested as supplemental components for semen 
extenders and assessed for their ability to increase post-storage survival for both cooled 
and frozen equine spermatozoa. Since the science of artificial insemination was first 
developed items such as skim milk, glucose, glycerol and egg yolk have been used to aid 
in preservation of equine, bovine, caprine, ovine, and human spermatozoa. Carnitine (L-
carnitine specifically) and pyruvate are two pivotal compounds for overall health and 
bodily function. This study was conducted to further assess the roles they play in survival 
of spermatozoa and to determine if they are an asset in equine semen handling, 
preservation, shipping and effectiveness once delivered in utero.   
Spermatozoa differ greatly from other cells in the stallion. Although spermatozoa 
function and survival is often assessed post-ejaculation, modifications and damages to its 
ability to perform can happen throughout generation and maturation within the stallion. 
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According to Amann and Graham (Equine Reproduction, 1993), the ability of 
spermatozoa to successfully fertilize the egg depends on five factors: 
1. Spermatozoa must have the ability to produce energy through metabolism. 
2. Spermatozoa must be progressively motile. 
3. The acrosome and the enzymes within must have the ability to break down 
and penetrate the wall of the ovum. 
 
4. There must be adequate lipid availability within the membranes for pre-
fertilization stability and capacity for membrane fusion when the spermatozoa 
and oocyte connect. 
 
5. Proteins that are necessary for survival in the mare tract and for spermatozoa 
to egg attachment must be present. 
 
Although the concept of fertilization is simple in theory, the constituent pieces 
that allow for a successful pregnancy can be complex.  When studying the male of any 
species, there are a significant number of factors that contribute to fertility.  The difficulty 
in semen research is the lack of a singular technique that can be applied across all the 
males of one species.  This issue is derived from the variation not only across breeds but 
also within breeds. In the equine, different breeds have been developed for their abilities 
in certain disciplines and events.  The characteristics that are selected are usually related 
to these abilities rather than to reproductive efficiency.  
This study evaluated motility, velocity, membrane status and acrosome status of 
the spermatozoa at increasing time increments post collection (2 hours, 24 hours, 48 
hours).  The practical application of this study was to ascertain the effectiveness of L-
carnitine and pyruvate in their ability to help with the longevity of the sample as is 
necessary for the 2-3 day time frame required for shipping frozen or cooled equine 
semen.   
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Problem Statement and Objective 
 Delivery of viable and motile equine spermatozoa for artificial insemination can 
be difficult due to the varying shipping schedules of mail carriers.  In order for 
spermatozoa to stay viable over the two to three day shipping time, spermatozoa must be 
suspended in extenders that provide adequate energy and protection. The objective of this 
study was to determine the effects of L-carnitine and pyruvate on motility, velocity, 
membrane status and acrosome status of cold stored stallion spermatozoa when added to 
diluents in commercially available equine semen extenders.  
 
Null Hypotheses 
1. L-carnitine and pyruvate supplementation of semen extenders will have no 
effect on motility, velocity, membrane status and acrosome status for stallion 
spermatozoa. 
2. There will be no difference in effects among extenders.  
 
 
 
 
 
 
 
 
 
4 
LITERATURE REVIEW 
 
Spermatozoa Structure 
 The general structures of spermatozoa are the plasma membrane, head, neck, 
midpiece, principal piece and end piece.  The structures of focus within this literature 
review are the plasma membrane, head and midpiece.   
 The lipid bilayer, the phospholipid-water interface, and the glycocalyx comprise 
the three zones of the plasma membrane.  Within the lipid bilayer are inward facing fatty 
acyl groups, which are the hydrophobic polar phospholipids, as well as outward facing 
charged polar head-groups, which are hydrophilic in nature.  The most common lipids in 
the plasma membrane are phospholipids and cholesterol.   
Proteins are likewise a significant part of the plasma membrane and make up 
approximately 50% of its matter (Dupuy et al., 2007).  Integral proteins provide 
necessary structure while peripheral proteins can be easily removed or replaced.  Integral 
proteins may also serve as pores, channels and receptors for media based substrates.  
Often times these proteins have carbohydrate chains, which have the ability to bind with 
medium-based proteins due to the net negative charge of the carbohydrate chain.   
Properties and composition of the glycocalyx have the potential for change 
depending on the effects caused by the addition of new material attaching to the 
carbohydrate chains of the integral proteins.  Within the plasma membrane in stallions, 
the ratio of cholesterol to phospholipid is 0.36 (Parks and Lynch, 1992). The major 
classes of phospholipids in the spermatozoa of most domestic species are: choline, 
ethanolamine, and sphingomyelin (Amann and Graham, 1993).  The cholesterol to 
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phospholipid (specifically those phospholipids that contain polyunsaturated acyl side 
chains) ratio generally characterizes the fluidity of the membrane. Higher levels of 
cholesterol will make the membrane more rigid.  Proper cholesterol levels maintain the 
integrity of the bilayer.  Most of the plasma membrane attachment is around the tail of 
the spermatozoa.  There are not a significant amount of attachment points that rigidly join 
the plasma membrane to the head of the spermatozoa (Aman and Graham, 1993).   
 The main regions of the head of the spermatozoa cell are the plasma membrane, 
the post-acrosomal lamina, the acrosome, the nuclear envelope and the nucleus (this is 
from the outer-most region to the innermost region).  In stallions, the head is wide and 
mostly flat.  The head generally tapers down from a thicker region near the midpiece to a 
thinner region approaching the rostral tip of the cell.  The enzymes housed in the 
acrosome, which are responsible for the penetration of the oocyte, are hyaluronidase, 
proacrosin, acrosin, and varying lipases.  A feature known as the perfatorium can 
sometimes be observed in the rostral tip of the acrosome and is believed to help provide 
structure.  The structures in the plasma membrane allow the spermatozoon to attach to the 
zona pellucida of the ovum, which catalyzes the beginning of the acrosome reaction 
(Flesch and Gadella, 2007). 
 The region from the base of the neck to the annulus is known as the midpiece.  
The matrix of mitochondria is held within this area of the spermatozoa cell.  
Approximately 50 helical turns (known as gyri) of mitochondria exist in the typical 
stallion spermatozoon.  A series of nine fibrous structures extend through the midpiece 
and provide the mechanical ability for movement.  The axoneme is in the central most 
region of the tail and is responsible for giving spermatozoa the potential for propulsion.  
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The annulus conjoins is a significant apparatus in joining the head and the tail of a 
spermatozoon (Gadella et al., 2008). 
 
Spermatozoa Metabolism 
 The study of spermatozoa metabolism helps discover the function of spermatozoa 
and the specific characteristics that need to be addressed to aid in preservation and 
survivability.  Spermatozoa, like other cells, must receive energy in the form of adenosine 
tri-phosphate, or ATP. Spermatozoa have the ability to utilize aerobic and anaerobic 
pathways for energy production.  The breakdown of glucose, lactate, and pyruvate as well 
the oxidation of amino acids and lipids are the subsidiary components of spermatozoa 
metabolism. Diffusion may provide substantial energy for flagella in species that produce 
spermatozoa of a smaller size; however, diffusion does not provide enough energy (ATP) 
through the mitochondria for continued function of the flagellum in species with larger 
spermatozoa (Ford, 2005).  This energy conundrum can be solved in part through the 
quick delivery of ATP through the use of the adenylate-kinase shuttle (Ford, 2005).  The 
presence of lactate within a population of spermatozoa is a player in spermatozoa 
metabolism. Lactate has historically been condemned as metabolic waste, but is now 
being classified as an essential component of cell metabolism as well as a player in 
intercellular and intracellular redox reactions (Gladden, 2004). There is some correlation 
in the production of L-lactate and overall spermatozoa survival. In swine, the production 
of L-lactate and the ratio of insemination to farrowing show a “relatively high 
correlation.”  (Rigau et al.,1996).  
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Cholesterol 
 The focus of this study was on the effects of L-carnitine and pyruvate; however, 
knowledge of the role of cholesterol in the overall production of ATP due to its influence 
over the process of fatty acid oxidation is essential. Unsaturated fatty acids are present in 
large quantities in the membranes of spermatozoa cells in mammals (Sikka, 1996).  As an 
integral component of structural integrity and survivability of spermatozoa, fatty acids 
must be maintained at adequate levels and ratios.  Intracellular fatty acids act as an 
energy source for spermatozoa as they can be oxidized to generate ATP for energy for the 
spermatozoa cells.  Subsequently, a lack of fatty acids will result in lack of substantial 
ATP production.  Lack of ATP means lack of motility for spermatozoa, lack of motility 
leads to lack of ability to fertilize an egg and thus an overall reduction in conception rates 
of females can occur. 
 One important cholesterol-binding molecule is known as HBCD (2-
hydroxypropyl-2-cyclodextrin). This molecule has the capacity to serve as a sink or a 
shuttle for cholesterol, depending on its current environment, which can subsequently 
raise or lower the concentration of cholesterol in the plasma membrane of the 
spermatozoa (Galantino-Homer et al., 2006). A higher ratio of cholesterol to 
phospholipids lowers the risk of cold shock to the spermatozoa.   
 A major issue with adding fatty acid compounds to semen extender is the 
hydrophobic nature of lipids that results in the inability of most fatty acid compounds to 
bind and integrate with water based media. The addition of cyclodextrins to a 
hydrophobic compound can allow for the compound to change its nature and become 
hydrophilic. This process is conceptually simple. A cyclodextrin is a cyclic sugar 
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molecule that can attach itself by surrounding another compound. When the cyclodextrin 
surrounds a lipid molecule, such as cholesterol, it allows the cholesterol to integrate with 
the water. The ability to add these fatty acids to semen extenders increases available 
substrates for spermatozoa metabolism.  A study on cholesterol (Christian et al., 1999) 
found that adding cyclodextrins at low levels to serum serves as a catalyst for a 
cholesterol shuttle that can transport cholesterol from cells to the lipoproteins within the 
serum. As a result, cyclodextrins possess the ability to manipulate the metabolism of 
cholesterol. The highest efficiency cholesterol shuttle in the tests conducted was the 
“double-decker” cyclophane. 
The ratio of cholesterol to phospholipids in an ejaculate is highest directly after 
ejaculation and decreases over time (Cross, 1998).  When spermatozoa are being 
capacitated, protein acceptor cells obtain the cholesterol that is released from the 
membrane of the spermatozoa while phospholipids are being brought in. The most 
important and abundant sterol in an ejaculate is cholesterol.  Density of cholesterol in the 
membranes of spermatozoa differs significantly across species. The recovery of motile 
spermatozoa post-thaw is improved when exogenous cholesterol is administered to the 
membranes of the spermatozoa prior to freezing (Purdy et al., 2004). 
 
Carnitine 
 Carnitine was named from the Latin word carnus, which means meat, because 
meat was the first location in which the compound was discovered. Different groups of 
Russian and German scientists discovered carnitine  (the Russian fraction being credited 
with the initial isolation) in 1905.  In 1948, scientists realized the necessity of this 
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compound in the survival of the larvae of mealworms.  They did not know that the 
compound they were dealing had been previously discovered and so it was dually named 
as vitamin BT until they later identified that this “vitamin Bt” was not fully functional as a 
vitamin and had already been classified as carnitine (Harmeyer, 2002).  The preliminary 
findings on the function of carnitine as a fatty acid transporter were conducted in the late 
1950’s. For many years, scientists questioned which isomer of the compound was 
biologically active.  L-carnitine was accepted as the biologically significant isomer in 
1962 and the early studies of the effects of carnitine deficiency were conducted in the 
early 1970’s. 
 Carnitine is a quaternary ammonium compound.  The proper chemical name of L-
carnitine is 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium.  L-carnitine has 
seven carbon atoms, fifteen hydrogen, one nitrogen, and three oxygen; lending the 
chemical formula of C7H15NO3 . In comparison to many organic molecules that exist 
within the body of an animal, carnitine is not a large compound.   
    L-carnitine is mainly produced in the kidneys and the liver. Carnitine does not have to 
be directly consumed in the diet of most mammals in order to maintain adequate levels 
for bodily function. The chief derivatives of carnitine are lysine and methionine (Higdon, 
2002).   
At most, there is only a variance of two carbon atoms, four hydrogen atoms, one 
nitrogen atom, one oxygen atom, and one sulfur atom when comparing these three 
molecules on any level. Most species create their own carnitine by a process that adds a 
methyl group to the amino acid lysine known as methylation (Bremer, 1983).  
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Carnitine plays a pivotal role as a transporter in the process of long-chain fatty 
acid oxidation (Hoppel, 2003).  Carnitine transports acyl groups to the mitochondrial 
stations within a cell once Β-oxidation of these long-chain fatty acids has occurred.  Once 
these acyl groups have arrived at the mitochondria, they are used for the production of 
acetyl-CoA, which can be used in the citric acid cycle for the production of ATP (Figure 
1).  Acetyl groups can also be transported within the cell.  Carnitine acetyl-transferase 
converts acetyl-CoA into acetyl-carnitine in a process known as the acetyl-carnitine 
shuttle (Hynes et al., 2011). To condense, carnitine aids in taking fatty acid substrates and 
mobilizing them for energy production by the cell (Childress et al., 1967). Carnitine is 
not only helpful in fatty acid metabolism, but is completely necessary for the process of 
oxidation of these molecules.  In order for oxidation of fatty acids (specifically within 
skeletal muscle) to occur; there must be adequate levels of carnitine present.  Within the 
mitochondrial matrix of a cell, species that use fatty acids for energy supply during flight, 
such as the common fly, must have high levels of carnitine to support and sustain this 
function.  However, species like the bee that utilize carbohydrates instead of fatty acids 
for this same function, do not need the same supply of carnitine (Childress et al., 1967). 
A study on prematurely weaned swine conducted by showed that overall 
metabolism of lipids was increased when swine were given exogenous L-carnitine.  The 
summary of data and research on L-carnitine suggests that the oxidation/metabolism of 
fatty acids is greatly improved due to the ability of L-carnitine to serve as an efficient 
transporter of metabolic substrates (Coffey et al., 1991). However, it should be noted that 
in a study of the effects of oral L-carnitine on semen quality in boars, no significant 
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(p<0.05) treatment effects were observed in the control diet versus a 500 mg per day 
supplemental diet (Kozink et al., 2004). 
Carnitine deficiencies lead to less efficient mobilization of fatty acids, decreased 
ATP production due to the lack of substrates available for ATP production, and the 
inability to oxidize lipids at a significant rate. Carnitine has great influence on heart 
health (Lango et al., 2001).  Although carnitine deficiency did not have an effect on 
cardiac function when observed on a short time scale in humans, an extended period of 
time with insufficient levels of carnitine could cause weakened performance of the heart 
and irregular patterns of function (Paulson, 1998).  The ability of the heart to contract 
with adequate strength and timing is especially reduced while performing under 
strenuous circumstances.  In relation to the function of carnitine in fatty acid metabolism, 
Paulson predicts that these low levels of carnitine lead to an inability of the cells within 
the heart to produce enough ATP to sustain proper energy output for contraction 
(Paulson, 1998).  A study on ischemic swine hearts showed that high levels of carnitine 
increase the ability of the cells to oxidize free fatty acids which may aid in removing 
these extra fatty acids from the cardiac cycle thus increasing the performance and health 
of the animal (Liedtke et al., 1981).  Carnitine deficiencies not only result in insufficient 
ATP production, as was observed in the Paulson study, but also in the inability of the 
system to rid itself of excessive amounts of free fatty acids that may be deleterious to 
overall function and performance of the heart.     
Human supplementation has become the most popular and widely applied area of 
carnitine use.  The role that carnitine plays in fatty acid metabolism makes it highly 
attractive to people desiring to be efficient in the burning of lipids during exercise and the 
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use of these lipids as a source of energy (Brass, 2000).  This same research suggests that 
carnitine may positively affect the balance of glucose within the system, biosynthesis of 
acyl-carnitine, and the ability of muscle to have longer endurance against fatigue 
(Roberts et al., 2004).  These exercise physiology researchers admit that more in depth 
and controlled trials are necessary to determine the absolute results of supplemental 
carnitine on overall bodily performance during exercise.  
Oral L-carnitine supplements have been shown to increase spermatozoa motility 
in humans when administered in a 3 to 4 month clinical trial (Higdon, 2002).  Added 
carnitine is hypothesized to aid in the prolonged survival of spermatozoa cells by 
increasing the ability of the individual spermatozoa to mobilize its fatty acids for 
sustained energy production.  This sustained energy production results in spermatozoa 
that stay viable and motile, meaning they have the ability to successfully fertilize an egg 
for a longer period of time. Few studies have been conducted on the effects of carnitine 
with the stallion but there has been evidence that seminal carnitine may serve as a 
potential semen quality marker and that carnitine may improve spermatozoa survival 
during storage (Stradaioli et al., 2000). 
 Research interest in carnitine has increased significantly from its earliest 
discovery and isolation to its most recent applications as a supplement for metabolic, 
cardiac and reproductive health and efficiency.  From the time that it is biosynthesized 
until it completes its role in transporting substrates for fatty acid oxidation, carnitine is an 
essential player in the bodily function of most mammals.  Although there are visible 
effects of deficiencies and observed improvements with supplementation, much research 
still needs to be conducted on the molecule that we know as carnitine.   
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Figure 1.  The role of L-carnitine in the production of ATP and substrate transfer between 
the cytosol and mitochondrial matrix.  (Roberts et al., 2004). 
 
 
Semen Processing 
When handling and processing semen for packaging, transport and use for 
breeding mares there is a significant effect on the survivability of the spermatozoa based 
upon the procedures and processing techniques used.  
Using a centrifuge to remove the seminal plasma from an ejaculate is one of the 
most common techniques and procedures used in semen processing. The amount of 
seminal plasma in an ejaculate is reduced to less than 5% of the original volume after 
centrifugation.  Removal of seminal plasma for cold storage is not as much of a routine 
procedure in Europe as it is in the United States, leading to decreased spermatozoa 
survival and fertility when shipping cold stored semen (Johannisson et al., 2009). 
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Centrifugation of semen in the equine is used to increase the concentration of 
spermatozoa within the ejaculate (Edmond et al., 2012). Greater motility, viability, 
spermatozoa chromatin integrity in treated compared to untreated samples (Johannisson 
et al., 2009).  In contrast, the body of centrifugation research shows individual animal 
variation in their response to centrifugation.  Two common centrifugation techniques are 
known as centrifugal fractionation and cushioned centrifugation. The technique of 
centrifugal fractionation is observed to enhance overall spermatozoa survival as it relates 
to motility, acrosome status and morphology (Edwards et al., 2012). The process of 
cushioned-centrifugation has the ability to collect large volumes of spermatozoa per 
ejaculate (Waite et al., 2008).   
Factors as seemingly unimportant as the shape of the tube that the sample is 
centrifuged in can also play a significant role in overall spermatozoa survival.  For 
example, recovery rate of the spermatozoa may be higher in tubes with a conical base, 
but overall spermatozoa survival values are greater when the tubes with the nipple base 
are used while being centrifuged (Waite et al., 2008).  Tube size can also have significant 
effects on spermatozoa survival. Spermatozoa handled in 50-ml tubes recover slower and 
have lower velocities than do spermatozoa handled in 15-ml tubes (Webb and Dean, 
2009). Volumes and concentrations of spermatozoa in extender likewise effect 
spermatozoa characteristics. When the percent seminal plasma in the sample is high, 
overall ratios of progressively motile spermatozoa are reduced (Dawson et al., 2000).  
Similarly, excessive amounts of semen per tube centrifuged can be damaging to 
spermatozoa.  When volumes of semen are centrifuged at levels less than or equal to 20 
ml, overall loss of spermatozoa is reduced (Ferrer et al., 2012). In addition, raising the 
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amount of spermatozoa in the sample to15-ml per tube may be deleterious to the recovery 
of spermatozoa (Edmond et al., 2012).    
Temperature at which spermatozoa are stored as well as sequence of cooling and 
thawing contributes to spermatozoa survival. When semen is stored close to the 0C 
level, DNA integrity and overall spermatozoa motility is reduced, compared to the result 
that spermatozoa remained quite viable over a 22-hour period when kept in conditions 
that ranged from 4C to 15C (Vidament et al., 2012). Progressively motile spermatozoa 
are shown to decrease after semen is thawed when samples are cooled prior to 
centrifugation (Squires et al., 2001). The process of centrifugation might briefly disrupt 
the spermatozoa membrane; however, further tests showed that they returned to normal 
after 48 hours (Johannisson et al., 2009). 
Several different types of semen extenders have been used as the general medium, 
pre-supplementation of other compounds, for the suspension of equine spermatozoa.  
Overall, INRA 82 (INRA and IMV-Technologies. L'Aigle, France) was shown to be a 
more adequate semen extender versus alternative treatments (Ijaz et al., 1995). When 
using INRA 82 and Kenney’s extenders (Reproduction Resources, Walworth, WI) overall 
spermatozoa survivability was greater to the 96-hour (INRA 82) and 48-hour (Kenney’s) 
markers when the compound taurine was added to the extender. Survivability of 
spermatozoa (cleaned and housed in Sp-Talp) that are incubated beforehand in extenders 
with taurine added increases (p<0.05) an extra 12 hours (INRA 82) or 24 hours 
(Kenney’s). The most current INRA extender is INRA 96 and is an improvement upon 
the original INRA 82. 
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The flow cytometer is a machine used for the analysis of spermatozoa at a rate of 
thousands of cells in a matter of seconds.  When an ejaculate is collected and suspended 
in extender it can be inserted into the flow cytometer for analysis.  A flow cytometer 
functions by stimulating individual cells to align one after another and pass through the 
reading apparatus.  The cells are exposed to a variety of dyes, depending on what factors 
the researcher desires to observe, in order for the machine to read specific characteristics. 
A high-energy beam of light or laser stimulates the cells to assort them in a single-file 
stream. Some of the traits that can be assessed by a flow cytometer are membrane status, 
acrosome status, sex, volume, size, mitochondrial status, apoptosis indicators, presence of 
ROS (reactive oxygen species), damaged DNA and spermatozoa capacitation (Marchetti 
et al., 2001).  This technology is often used in the medical field to look for disorders 
within the blood, cancer markers and other medical indicators but has been widely 
adapted for use in reproductive and fertility research and practice. 
Most recently, flow cytometers are being calibrated to sort semen by sex of 
individual spermatozoa.  This practice is becoming more widely used in the cattle 
industry.  The equine industry is beginning preliminary work on the use of the flow 
cytometer for sex-sorting stallion semen; however, there has been some difficulty (Gibb 
et al., 2010) This issue arose from the inability of the flow cytometer to recognize 
differences due to the opaque nature of the extenders (skim milk, egg yolk, etc.).  When a 
more transparent semen extender was used instead of skim milk, there was a significant 
increase in the efficiency of sex sorting by the flow cytometer (Gibb et al., 2010).   
Flow cytometers have been used to look for spermatozoa that have suffered 
damage to their chromatin. An assay known as the DNA Fragmentation Index (DFI) is 
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positively correlated with lower fertility, decreased conception rates, and increased 
“spontaneous miscarriage” in humans (Virro et al., 2004).  A myriad of problems still 
exist with flow cytometers that necessitate further study or investigation.  
Cost issues can exist with technologies for each machine.  For instance, specific 
lasers can only excite certain dyes.  Purchase of multiple dye-specific lasers is costly.  
Cost of the machine itself is also quite heavy, many machines starting around the $50,000 
range.  Operator efficiency and accuracy is of paramount importance with flow 
cytometers.  Using the wrong dyes or lasers, calibrating the machine incorrectly or 
improperly setting parameters through the machine’s software can completely ruin an 
analysis or give inaccurate results. Electronic interference from other machines near the 
flow cytometer can likewise cause issues.  When using dyes, it is important to know how 
different dyes affect one another.  For instance, there can be fluorescent cross-
contamination of dyes or complete blocking of the effectiveness of one dye by another 
dye.   
The machine can also produce a series of false results depending on the scenario.  
It is important to analyze spermatozoa by human quantification through a microscope 
(subjective analysis) along with the use of the machine (flow cytometers, CASA 
machines, etc.) to verify machine settings and accuracy (Johannisson et al., 2009).  In 
CASA analysis a correlation of r=0.65 was observed between “subjective” analyzed 
spermatozoa and CASA analyzed spermatozoa, showing good calibration of the CASA 
machine (Johannisson et al., 2009).  Some dyes are designed to stain the acrosome to 
check for acrosome status; however, over-damaged acrosomes lose their receptors that 
act as binding sites for the dye.  A completely damaged acrosome cannot absorb the dye, 
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just as a completely intact acrosome would.  Misreading debris within the sample can 
cause false-positive or false-negative results.  Bacteria that have membranes similar to 
spermatozoa are often counted as spermatozoa by the flow cytometer leading to an over 
estimation of viable cells.  Similar misreading can occur in the machine from blood, 
epithelial cells, gel and extender particles that are present in the sample. 
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METHODS 
 
Experiment 1 
 Collection and Processing.  Four ejaculates from each of two stallions (1 
American Quarter Horse, 1 Miniature horse) were collected using an artificial vagina 
(AV) and the semen passed through a filter into the collection bottle.  Directly after the 
collection, the gel portion of the ejaculate was once again filtered off of the semen if 
necessary.  Semen was then analyzed for volume (mL) and concentration (million 
spermatozoa per mL) using a 590B Densimeter (Animal Reproduction Systems, Chino, 
CA).  Semen was then divided into two sets of four test tubes, half of which were 
centrifuged at 350 g-force for two to four minutes depending on visual estimation of 
proper effects of centrifugation.   
Extenders were prepared and frozen for use throughout the experiment.  Two 
different extenders were used for Experiment 1, Kenney’s SKMG (K) and INRA 96 (I).  
Base tubes were labeled as A1-A8 for stallion 1 (QH) and C1-C8 for stallion 2 (MH) and 
were comprised of one of the two extenders (K or I), centrifuged or non-centrifuged (S 
for centrifuged), and supplemented with L-carnitine and pyruvate or not supplemented (C 
for carnitine and pyruvate).  Labels were as follows: 1: K, 2: KS, 3: KC, 4: KCS, 5: I, 6: 
IS, 7: IC, 8: ICS.  Treatment numbers were also preceded with A or C for stallions 1 and 
2 respectively.  Carnitine was added to the extender at the rate of 1.612 grams per 200 
mL of extender.  Pyruvate was added at the rate of 0.22008 grams per 200 mL.  INRA 96 
is delivered in 200 mL bottles, hence the 200 mL basis.  The sterile water portion of 
Kenney’s is delivered in 92 mL bottles; therefore, the amount of Kenney’s extender was 
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doubled to make 184 mL and then 16 mL of distilled water was added to create an equal 
volume to add carnitine and pyruvate to both extenders.   
Extenders were thawed prior to collection of the stallions and were quality 
controlled to a temperature of 30C to 35C before semen was added to ensure that the 
spermatozoa did not undergo cold shock.  Each sample was extended from 3:1 (extender: 
semen) to 5:1 depending on the concentration of the sample to ensure that there were at 
least 300 million spermatozoa per test tube.  Each test tube (A1 through A8 and C1 
through C8) was then divided into four 1-½ mL aliquots to be used as the four sub-
samples for analysis.  The four sub-samples of each treatment were placed in Equine 
Express II™ containers for cooling and were labeled for computer assisted sperm 
analysis (CASA) at 2 hours, 24 hours, and 48 hours post-collection and for flow 
cytometer analysis at 24 hours post-collection.   
 CASA.  Each sample was inverted by hand to ensure proper mixing when 
removed from the cooling containers.  Droplets were taken from each sample with a 
micropipette and placed on 20 micron 4 chamber slides.  Slides were placed on a slide 
warmer for five minutes to ensure that spermatozoa thawed to full motility and were no 
longer experiencing the effects of cooling.  Each chamber was then assessed by CASA 
and results were recorded manually.  The parameters assessed by CASA were total 
motility (TM), progressive motility (PM), average path velocity (VAP), straight-line 
velocity (VSL), curvilinear velocity (VCL) and elongation (ELONG).    
 Flow Cytometer.  Each sample was vortexed on a Fisher Vortex Genie 2 
(Scientific Industries Inc. Bohemia, NY) for one to two seconds to ensure the sample was 
mixed homogenously.  Samples of 50 L were taken from each treatment’s base tube 
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using a micropipette and placed into 1 mL tubes for staining and preparations for the flow 
cytometer. Three different stains were used.  Intact membranes and disrupted membranes 
were assessed using SYBR14 and Propidium Iodide (PI) stains.  FITC-PSA was used to 
stain for reacted acrosomes (unstained cells signified acrosomes that were not yet 
reacted). 16 tubes were used for each ejaculate (8 for SYBR14/PI and 8 for FITC-PSA).  
A quantity of 5 L of SYBR14 and 5 L of PI was added to each of 8 samples of 50 L 
of semen. Treatments were vortexed for one to two seconds and then placed in a cabinet 
to incubate in the dark for 20 minutes.  10 L of FITC-PSA were added to each of 8 
samples of 50 L of semen.  Treatments were vortexed for one to two seconds again and 
then placed in a cabinet to incubate in the dark for 10 minutes.  FITC-PSA is extremely 
time sensitive and caution must be taken to not over-stain the samples.  After the 
incubation period, 100 L of Ham’s 10 HEPES diluent was added to each sample and 
then samples were once again vortexed for one to two seconds prior to flow cytometer 
analysis.  Samples were then run through the flow cytometer and results were recorded 
manually and within the memory of the computer. 
 
Experiment 2 
 Collection and processing.  Four ejaculates from each of three stallions (2 
Arabians (A), 1 Miniature horse) were collected in the same manner as described in 
Experiment 1. Volume and concentration were recorded in the same manner as 
Experiment 1.  Three different extenders were prepared and frozen for use throughout the 
experiment.  Extenders used were EZ-Mixin (Animal Reproduction Systems) SKMG (K), 
INRA 96 (I), and Revolution (Santa Cruz Biotechnology, Dallas, TX) SKMG (R).   
22 
 Centrifugation was eliminated from Experiment 2 due to the deleterious effects 
of centrifugation observed in some of the stallions during Experiment 1.  Treatment tubes 
were labeled as C1-C6 for stallion 1 (MH), T1-T6 for stallions 2 (A), and X1-X6 for 
stallion 3 (A).  Treatments consisted of one of the three extenders and were either 
supplemented with carnitine/pyruvate combination as in Experiment 1 or were not 
supplemented.  Carnitine/pyruvate supplemented extenders were annotated with the label 
of (+).  Treatment labels were as follows 1: K, 2: K+, 3: I, 4: I+, 5: R, 6: R+.  Treatment 
labels were also preceded with C, T, or X for stallions 1, 2, and 3.  In this experiment, 
distilled water was not added to the extenders to equal the 200mL that we standardized 
from the INRA 96 volume.  Concentration per unit volume; however, was standardized 
from Experiment 1 to Experiment 2 and was equivocated to the ratio of 1.612 grams of 
carnitine and 0.22008 grams of pyruvate per 200mL volume of extender.  All further 
processing of semen was done according to the protocol described in Experiment 1. 
 CASA.  CASA analysis was conducted according to the same procedures and 
protocols discussed in Experiment 1. 
 Flow Cytometer.  Flow cytometer analysis was likewise conducted according to 
the procedures and protocols discussed in Experiment 1.   
 
Statistics 
 The GLM procedure of ANOVA was used in Minitab for treatment analysis.  
Tukey’s pairwise comparisons were used for analysis of L-carnitine and pyruvate effects 
as well as extender effects.  For ANOVA, the model consisted of stallion, ejaculate 
(nested within stallion) and time (nested within ejaculate).    
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IACUC Compliance 
 These experiments were conducted in compliance with the International Animal 
Care and Use Committee (IACUC) and can be found under the protocol name 
“Techniques to Improve Stallion Semen Preservation.” The IACUC identification 
number is 13-027.0-A.  
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RESULTS 
 
Experiment 1 
Experiment 1 mean values ± standard deviations for L-carnitine and pyruvate 
treated aliquots compared to untreated aliquots assessed by CASA at 2 hours, 24 hours 
and 48 hours post collection and by flow cytometer at 24 hours post collection were 
recorded.  Total motility and progressive motility are recorded in Table 1. The effects of 
VAP, VSL, VCL and elongation are recorded in Table 2.  The percentage of intact 
membranes (% SYBR), disrupted membranes (% PI), intact acrosomes (% unstained), 
and reacted acrosome (% FITC-PSA) are recorded in Table 3.  Main effects of stallion, 
ejaculate (nested within stallion), centrifugation, extender, L-carnitine and pyruvate 
treatment, and time are listed with p-values in Table 4.  Tukey’s comparisons of L-
carnitine and pyruvate treatment effects are listed in Table 5 and Table 6.  Tukey’s 
comparisons of extender effects are listed in Table 7 and Table 8.   
When observing L-carnitine and pyruvate treatment effect, the only statistically 
different period (p<0.05) of observation was 48 hours post-collection progressive 
motility.  The visual means show trends; the reasons for the lack of within time difference 
will be addressed within the “Discussion” section of this thesis.   
Multiple significant (p<0.05) main effects existed when observed across all 
stallions, ejaculates, times and treatments.  Stallion effect was significant for VCL.  
Ejaculate effect was significant for TM, PM, VAP, ELONG, % SYBR, % PI, % 
unstained and % FITC-PSA.  Centrifuge effect was significant for VAP.  INRA was 
superior to SKMG (p<0.05) for TM and PM.  L-carnitine and pyruvate treatment effect 
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was superior to control for TM and PM.  Time effect was significant for TM, PM, VAP, 
VSL, VCL and ELONG (note: Time was not a factor for % SYBR, % PI, % unstained 
and % FITC-PSA).  
 
Experiment 2 
Experiment 2 mean values ± standard deviations for L-carnitine and pyruvate 
treated aliquots compared to untreated aliquots assessed by CASA at 2 hours, 24 hours 
and 48 hours post collection and by flow cytometer at 24 hours post collection were 
recorded.  Total motility and progressive motility are recorded in Table 9. VAP, VSL, 
VCL and Elongation are recorded in Table 10.  The percentage of intact membranes (% 
SYBR), disrupted membranes (% PI), intact acrosomes (% unstained), and reacted 
acrosome (% FITC-PSA) are recorded in Table 11.  Main effects of stallion, ejaculate 
(nested within stallion), centrifugation, extender, L-carnitine and pyruvate treatment, and 
time are listed with p-values in Table 12.  Tukey’s comparisons of L-carnitine and 
pyruvate treatment effects are listed in Table 13 and Table 14.  Tukey’s comparisons of 
extender effects are listed in Table 15 and Table 16.   
There were no significant treatment effects (p<0.05) when comparing means 
across individual times.  As in Experiment 1, the reasons for the lack of difference will be 
addressed within the “Discussion” section of this thesis. 
In parallel with Experiment 1, many main effects existed when observing means 
with all stallions, ejaculates, times and treatments included.  Stallion effect was 
significant for TM, PM, VAP, VSL, VCL, ELONG, % unstained and % FITC-PSA.  
Ejaculate effect was significant for TM, VAP, % SYBR and % PI.  The INRA extender 
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was superior (p<0.05) to SKMG and REV for TM and PM.  These findings are in 
agreement with the literature.  L-carnitine and pyruvate treatment effect was superior 
(p<0.05) to the control for TM and PM.  Time effect was significant for TM, PM, VAP, 
VSL, VCL and ELONG (note: Time was not a factor for % SYBR, % PI, % unstained 
and % FITC-PSA.
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Table 1.  Experiment 1 CASA means ± SD for total motility (TM) and progressive motility (PM) across extender, centrifugation and 
L-carnitine/pyruvate treatment (CP) at 2 hours, 24 hours, and 48 hours post collection. 
 
SKMG INRA 96 
 
Not Centrifuged Centrifuged Not Centrifuged Centrifuged 
 
CP- CP+ CP- CP+ CP- CP+ CP- CP+ 
TM 
          2h 65.9±19.3 79.3±11.7 70.7±16.0 75.0±11.7 76.5±13.0 78.1±13.8 73.8±10.7 78.8±11.8 
  24h 67.0±16.3 69.3±13.6 62.5±15.1 68.5±12.2 71.4±14.1 76.3±13.6 75.4±15.4 70.3±13.2 
  48h 58.6±18.8 70.0±10.0 67.9±14.9 62.4±16.9 76.6±14.9 76.3±9.7 74.5±15.2 69.5±10.4 
PM 
          2h 50.0±15.0 60.1±11.4 53.9±15.5 59.1±11.7 59.5±14.0 62.6±15.2 57.8±14.7 62.6±15.8 
  24h 47.0±14.2 56.4±13.1 48.5±16.4 59.1±11.8 53.6±16.5 59.6±13.0 59.6±18.6 55.9±13.4 
  48h 40.3±11.4
b
 52.9±7.32
ab
 54.8±14.2
ab
 59.1±11.9
ab
 58.5±12.9
b
 56.3±7.6
ab
 61.8±10.6
a
 55.1±9.2
ab
 
Note: means and standard deviations within a row with different superscripts are different (p<0.05).
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Table 2.  Experiment 1 CASA means ± SD for active path velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL), 
and elongation (ELONG) across extender, centrifugation and L-carnitine/pyruvate treatment (CP) at 2 hours, 24 hours and 48 hours 
post collection. 
 
SKMG INRA 96 
 
Not Centrifuged Centrifuged Not Centrifuged Centrifuged 
 
CP- CP+ CP- CP+ CP- CP+ CP- CP+ 
VAP 
        
  2h 114.9±16.0 117.8±16.3 123.6±16.0 122.5±13.2 119.2±10.3 116.4±14.6 112.6±17.2 115.8±9.7 
  24h 122.2±5.8 119.0±9.7 119.7±9.9 114.2±7.1 125.0±10.5 118.9±8.0 117.7±11.9 111.7±7.4 
  48h 117.5±10.8 110.0±17.8 114.0±14.8 100.9±14.2 115.0±9.1 99.8±15.8 104.0±12.2 101.9±11.0 
VSL 
        
  2h 96.8±14.6 97.4±14.3 100.2±14.2 103.2±13.8 100.3±10.2 99.0±14.9 91.3±15.7 97.5±11.5 
  24h 98.2±11.3 103.3±12.2 97.5±9.6 100.0±6.4 101.8±11.5 98.5±8.5 94.0±10.7 95.1±7.4 
  48h 95.0±6.1 91.1±11.4 92.7±10.5 87.4±10.6 93.4±6.1 83.9±10.0 88.4±9.4 87.4±9.6 
VCL 
        
  2h 178.5±25.4 183.6±32.5 206.9±28.5 196.1±26.2 189.4±21.8 178.4±21.2 189.8±33.8 187.8±24.0 
  24h 204.5±11.1 196.1±39.7 204.2±27.4 182.1±22.4 205.3±29.6 193.5±31.1 202.5±28.1 181.5±24.9 
  48h 193.2±23.5 180.3±42.4 195.0±29.3 162.2±26.6 195.3±23.1 161.0±38.7 169.8±26.0 161.4±21.0 
ELONG 
        
  2h 65.5±4.3 65.1±4.7 65.3±6.1 64.8±5.1 65.1±6.1 65.8±4.5 65.9±6.1 66.0±5.4 
  24h 62.9±3.3 64.9±3.1 62.6±3.3 64.8±4.2 62.3±3.8 65.0±2.5 64.5±2.9 63.8±3.4 
  48h 63.5±4.7 64.8±4.7 64.3±4.9 65.4±4.0 64.4±4.3 64.6±5.5 65.0±5.4 64.5±3.9 
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Table 3.  Experiment 1 flow cytometer means ± SD for intact membranes (% SYBR), disrupted membranes (% PI), unreacted 
acrosomes (% unstained) and reacted acrosomes (% FITC-PSA) across extender, centrifugation and L-carnitine/pyruvate treatment 
(CP) 24 hours post collection. 
 
SKMG INRA 96 
 
Not Centrifuged Centrifuged Not Centrifuged Centrifuged 
 
CP- CP+ CP- CP+ CP- CP+ CP- CP+ 
% SYBR 67.8±7.7 71.6±6.7 66.0±12.3 69.1±13.0 75.6±7.1 77.0±6.9 73.8±13.4 69.2±11.5 
 
% PI 32.2±7.7 28.4±6.7 34.0±12.3 31.0±13.0 24.4±7.1 23.0±6.9 26.2±13.4 30.9±11.5 
 
% unstained 65.6±13.0 64.6±12.7 63.5±16.1 64.4±15.1 61.5±12.5 67.5±15.8 65.0±19.0 64.3±15.9 
 
% FITC 34.4±13.0 35.4±12.7 36.5±16.1 35.6±15.2 38.5±12.5 32.5±15.8 35.1±19.0 35.7±15.9 
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Table 4.  Experiment 1 p-values for effect of stallion, ejaculate (nested within stallion), 
centrifugation, extender, L-carnitine/pyruvate (CP) and time on TM, PM, VAP, VSL, 
VCL, ELONG, % SBYR, % PI, % unstained and % FITC-PSA.  (Note: % SYBR, %PI, 
% unstained and % FITC-PSA were not subject to multiple time analysis. 
  Stallion Ejaculate Centrifuge Extender CP Time 
TM 0.121 0.000 0.610 0.000 0.001 0.021 
PM 0.061 0.005 0.839 0.000 0.000 0.000 
VAP 0.773 0.047 0.018 0.523 0.005 0.000 
VSL 0.345 0.353 0.122 0.546 0.135 0.000 
VCL 0.028 0.088 0.300 0.616 0.008 0.012 
ELONG 0.988 0.001 0.852 0.815 0.003 0.000 
% SYBR 0.080 0.000 0.176 0.000 0.015 N/A 
% PI 0.080 0.000 0.176 0.000 0.015 N/A 
% unstained 0.657 0.000 0.893 0.820 0.340 N/A 
% FITC 0.657 0.000 0.893 0.820 0.340 N/A 
 
 31 
Table 5.  Experiment 1 Tukey’s comparisons of CP effect on TM, PM, VAP, VSL, VCL 
and ELONG with all times and extenders included.   
  CP- CP+ 
TM 70.1±15.57
b
 72.8±12.8
a
 
PM 53.8±15.1
b
 57.3±12.1
a
 
VAP 117.1±12.9
a
 112.4±14.0
b
 
VSL 95.8±11.2 95.3±12.2 
VCL 194.5±27.0
a
 180.3±30.9
b
 
ELONG 64.3±4.6
b
 64.9±4.1
a
 
Note: means and standard deviations within a row with different superscripts are different 
(p<0.05). 
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Table 6. Experiment 1 Tukey’s comparisons of CP treatment effects on TM, PM, VAP, VSL, VCL and ELONGATION by extender 
and centrifugation with all times included. 
 
SKMG SKMG SKMG SKMG INRA INRA INRA INRA 
 
Not-Cent Cent Not-Cent Cent Not-Cent Cent Not-Cent Cent 
 
CP- CP- CP+ CP+ CP- CP- CP+ CP+ 
TM 63.8±17.8d 67.0±15.1cd 72.8±12.3abc 68.6±14.2bcd 74.8±13.6ab 74.5±13.4ab 76.9±12.0a 72.8±12.1abc 
PM 45.8±13.7c 52.4±15.0b 56.5±10.8ab 55.3±12.7ab 57.2±14.1ab 59.7±14.4a 59.5±12.1a 57.9±13.0ab 
VAP 118.2±11.5ab 119.1±13.8ab 115.6±14.9abc 112.6±14.5abc 119.7±10.4a 111.4±14.5bc 111.7±15.3abc 109.8±10.8c 
VSL 96.7±10.8ab 96.8±11.5ab 97.3±13.1ab 96.9±12.4ab 98.5±9.9a 91.2±11.9b 93.8±13.1ab 93.3±10.2ab 
VCL 192.1±22.8abc 202.1±27.6a 186.7±37.4abc 180.1±27.9bc 196.7±24.9ab 187.36±31.3abc 177.7±32.7c 176.9±25.1c 
ELO 64.0±4.1 64.0±4.8 64.9±4.1 65.0±4.3 63.9±4.8 65.1±4.8 65.1±4.2 64.8±4.2 
Note: means and standard deviations within a row with different superscripts are different (p<0.05). 
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Table 7.  Experiment 1 Tukey’s comparisons of extender effect on TM, PM, VAP, VSL, 
VCL and ELONG with all times and CP treatments included. 
  SKMG INRA 
TM 68.1±15.1
b
 74.8±12.7
a
 
PM 52.5±13.6
b
 58.6±13.3
a
 
VAP 116.4±13.8
a
 113.2±13.3
b
 
VSL 96.9±11.8
a
 94.2±11.5
b
 
VCL 190.2±30.0 184.6±29.4 
ELONG 64.5±4.3 64.7±4.5 
Note: means and standard deviations within a row with different superscripts are different 
(p<0.05). 
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Table 8. Experiment 1 Tukey’s comparisons of extender effects on TM, PM, VAP, VSL, 
VCL and ELONGATION with all times included. 
 
SKMG INRA 
TM 68.1±15.1
b
 74.8±12.7
a
 
PM 52.5±13.6
b
 58.6±12.3
a
 
VAP 116.4±13.8
a
 113.2±13.3
b
 
VSL 96.9±11.8
a
 94.2±11.5
b
 
VCL 190.2±30.0 184.6±29.4 
ELONG 64.5±4.3 64.7±4.5 
 
  
3
5
 
Table 9.  Experiment 2 CASA means ± SD for total motility (TM) and progressive motility (PM) across extender and L-
carnitine/pyruvate treatment (CP) at 2 hours, 24 hours, and 48 hours post collection. 
 
SKMG INRA 96 REV 
 
CP- CP+ CP- CP+ CP- CP+ 
TM 
        2h 78.0±13.9 82.8±13.3 85.9±11.8 87.8±9.7 78.0±14.6 82.8±11.9 
  24h 77.7±17.6 80.4±15.0 79.1±18.3 80.8±14.9 73.8±18.3 72.6±17.1 
  48h 68.8±21.5 74.3±18.4 75.4±18.9 78.7±13.5 58.3±23.0 66.4±17.8 
PM 
        2h 62.3±13.3 66.2±11.9 72.2±11.0 74.2±8.1 63.8±12.1 68.7±10.0 
  24h 57.3±16.6 57.8±17.4 59.4±17.9 62.1±15.4 53.8±17.5 56.4±16.7 
  48h 46.3±18.1 52.8±17.4 54.3±17.4 59.3±13.0 42.5±17.5 47.2±15.4 
 
  
3
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Table 10. Experiment 2 CASA means ± SD for active path velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL), 
and elongation (ELONG) across extender and L-carnitine/pyruvate treatment (CP) at 2 hours, 24 hours and 48 hours post collection. 
 
SKMG INRA 96 REV 
 
CP- CP+ CP- CP+ CP- CP+ 
VAP 
        2h 114.9±13.9 123.1±15.7 120.4±10.1 117.6±13.8 121.0±14.1 119.6±14.7 
  24h 118.3±23.1 121.0±14.2 114.5±18.5 107.0±13.6 119.3±24.4 118.2±14.6 
  48h 113.6±22.5 111.8±18.7 117.7±21.4 105.9±10.4 115.1±18.3 105.0±11.7 
 
VSL 
        2h 98.7±12.1 104.6±14.6 103.5±6.4 101.8±10.5 106.4±11.7 105.7±12.5 
  24h 94.3±14.8 97.4±10.3 95.0±12.8 89.8±7.9 97.3±16.4 92.7±10.6 
  48h 88.8±15.3 88.3±11.6 95.7±12.3 85.5±7.3 92.0±11.8 84.4±6.6 
 
VCL 
        2h 181.7±19.5 192.9±26.1 186.9±22.1 178.8±28.1 182.4±23.6 117.2±25.9 
  24h 204.5±45.8 214.0±33.1 190.2±38.6 178.5±35.5 204.3±49.7 190.0±34.4 
  48h 200.8±43.5 202.2±43.7 203.6±46.3 184.5±33.9 208.1±154.6 190.5±35.1 
 
ELONG 
        2h 60.8±1.9 60.8±1.3 61.6±1.2 60.8±1.5 61.5±2.2 61.2±2.0 
  24h 60.7±1.8 60.4±2.4 60.8±2.1 61.3±1.7 60.3±2.1 60.5±2.6 
  48h 60.6±2.2 60.8±2.6 60.3±2.3 61.3±1.6 60.2±2.1 60.5±1.8 
  
3
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Table 11.  Experiment 2 flow cytometer means ± SD for intact membranes (% SYBR), disrupted membranes (% PI), unreacted 
acrosomes (% unstained) and reacted acrosomes (% FITC-PSA) across extender and L-carnitine/pyruvate treatment (CP) 24 hours 
post collection. 
 
SKMG INRA 96 REV 
 
CP- CP+ CP- CP+ CP- CP+ 
% SYBR 60.9±10.2 67.9±5.8 77.2±7.1 79.9±4.5 87.0±2.6 86.2±5.3 
 
% PI 39.1±10.2 32.1±5.8 22.8±7.1 20.1±4.5 13.0±2.6 13.8±5.3 
 
% unstained 63.0±21.2 77.9±4.6 65.8±17.6 80.7±6.4 69.8±13.7 78.0±7.3 
 
% FITC-PSA 37.0±21.2 22.1±4.6 34.2±17.6 19.3±6.4 30.2±13.7 22.0±7.3 
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Table 12.  Experiment 2 p-values for effect of stallion, ejaculate (nested within stallion), 
extender, L-carnitine/pyruvate (CP) and time on TM, PM, VAP, VSL, VCL, ELONG, % 
SBYR, % PI, % unstained and % FITC-PSA.  (Note: % SYBR, %PI, % unstained and % 
FITC-PSA were not subject to multiple time analysis. 
  Stallion Ejaculate  Extender CP Time 
TM 0.005 0.050 0.000 0.003 0.000 
PM 0.001 0.319 0.000 0.000 0.000 
VAP 0.001 0.007 0.162 0.01 0.000 
VSL 0.007 0.222 0.625 0.033 0.000 
VCL 0.000 0.064 0.001 0.021 0.000 
ELONG 0.000 0.290 0.354 0.618 0.001 
% SYBR 0.224 0.012 0.000 0.028 N/A 
% PI 0.224 0.012 0.000 0.028 N/A 
% unstained 0.004 0.591 0.567 0.000 N/A 
% FITC-PSA 0.004 0.591 0.567 0.000 N/A 
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Table 13.  Experiment 2 Tukey’s comparisons of CP effect on TM, PM, VAP, VSL, VCL 
and ELONG with all times and extenders included.  
  CP- CP+ 
TM 75.0±18.7
b
 78.5±15.5
a
 
PM 56.9±17.5
b
 60.5±15.8
a
 
VAP 117.2±18.5
a
 113.6±15.3
b
 
VSL 96.8±13.5
a
 94.5±12.7
b
 
VCL 195.8±38.5
a
 189.8±34.0
b
 
ELONG 60.7±2.0 60.8±2.0 
Note: means and standard deviations within a row with different superscripts are different 
(p<0.05). 
 
 
 
  
4
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Table 14. Experiment 2 Tukey’s comparisons of CP treatment effects on TM, PM, VAP, VSL, VCL and ELONGATION by extender 
with all times included. 
 
SKMG SKMG INRA INRA REV REV 
 
CP- CP+ CP- CP+ CP- CP+ 
TM 74.8±17.9
bcd
 79.2±15.7
abc
 80.1±16.8
ab
 82.4±13.1
a
 70.1±20.3
d
 73.9±16.8
cd
 
PM 55.3±17.1
cd
 58.9±16.3
bc
 62.0±17.1
ab
 65.2±13.8
a
 53.4±17.8
d
 57.4±16.5
bcd
 
VAP 115.6±19.8
ab
 118.6±16.6
a
 117.5±17.0
a
 110.1±13.4
ab
 118.5±19.0
a
 111.9±14.7
ab
 
VSL 93.9±14.3
ab
 96.8±13.7
ab
 98.1±11.3
a
 92.4±10.9
b
 98.6±14.4
a
 94.26±13.3
ab
 
VCL 195.7±38.4
ab
 203.0±35.2
a
 193.6±36.7
ab
 180.6±31.8
c
 198.3±41.3
ab
 185.9±31.8
bc
 
ELONG 60.7±1.9 60.7±2.1 60.9±2.0 61.1±1.6 60.7±2.2 60.7±2.1 
Note: means and standard deviations within a row with different superscripts are different (p<0.05).
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Table 15. Experiment 2 Tukey’s comparisons of extender effect on TM, PM, VAP, VSL, 
VCL and ELONG with all times and CP treatments included. 
  SKMG INRA REV 
TM 77.0±16.9
b
 81.3±15.0
a
 72.0±18.6
c
 
PM 57.1±16.7
b
 63.6±15.5
a
 55.4±17.2
b
 
VAP 117.1±18.2 113.8±15.7 115.2±17.2 
VSL 95.3±14.0 95.2±11.4 96.4±13.9 
VCL 119.4±36.8
b
 187.1±34.7
ab
 192.1±37.1
a
 
ELONG 60.7±2.0 61.0±1.8 60.7±2.2 
Note: means and standard deviations within a row with different superscripts are different 
(p<0.05).
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Table 16. Experiment 2 Tukey’s comparisons of extender effects on TM, PM, VAP, 
VSL, VCL and ELONGATION with all times included. 
  SKMG INRA REV 
TM 77.0±16.9
b
 81.3±15.0
a
 72.0±18.6
c
 
PM 57.1±16.7
b
 63.6±15.5
a
 55.4±17.2
b
 
VAP 117.1±18.2 113.8±15.7 115.2±17.2 
VSL 95.3±14.0 95.2±11.4 96.4±13.9 
VCL 199.4±36.8
a
 187.1±34.7
b
 192.1±37.1
ab
 
ELONG 60.7±2.0 61.0±1.8 60.7±2.2 
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DISCUSSION 
 
Experiment 1 
 When data were analyzed within specific times (Tables 1-3) there was only one 
point of significant treatment difference observed (PM at 48 hours).  However, when 
observing the means of each treatment, there are visible visual trends that show 
difference between these treatments.  The lack of statistical significance is most likely 
due to inadequate degrees of freedom available when running the analysis of variance on 
treatment differences.  The small sample size is causative of the limited degrees of 
freedom.  Variation in the innate characteristics of our sample position may also be 
causative of this.  One of the greatest difficulties in equine reproduction research is lack 
of uniformity in the different stallions used for a particular experiment.  Similarly, there 
is a lack of uniformity in different ejaculates from the same stallion (this can be partially 
adjusted for by nesting the ejaculate effect within the particular stallion).   
 In this analysis the degrees of freedom are much higher; therefore the strength of 
extender as well as L-carnitine and pyruvate treatment are visible. An increase in sample 
size may result it significant differences in analysis of variance at each of the individual 
storage times.   
 
Experiment 2 
 The results of the Experiment 2 are similar to the results of Experiment 1.  
Analysis at individual time points failed to show significant treatment effects. Limitations 
due to stallion effect and ejaculate effect were likewise an issue within this experiment. 
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 Conversely, extender and L-carnitine and pyruvate treatment showed multiple 
points of significance when including all times in the analysis of variance.  The 
assumption remains in this experiment that an increased sample size would have 
potentially led to statistically different results across different treatments for individual 
time analysis. 
 
Limitations 
 Semen research can be highly sensitive to multiple extraneous factors.  When 
dealing with such environmentally dependent material, it is imperative to maintain 
structured procedures and precise technical work to eliminate as much operator error and 
environmental influence as possible.  As mentioned above, the issues of stallion effect 
and ejaculate effect are continuing areas of difficulty for adjustment in this research.  
Characteristic differences are highly variable across breeds but they are likewise variable 
within breeds.   
 Overall, in an increase in the number of stallions available, number of ejaculates 
from each stallion and continued improvement of technical precision would have led to 
an even stronger base of data to analyze the effects of extender and L-carnitine/pyruvate 
treatments. 
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CONCLUSIONS 
 
The inclusion of L-carnitine and pyruvate to a variety of semen extenders has the 
potential to improve the media in which spermatozoa are housed during transportation for 
the purpose of artificial insemination.  The response of spermatozoa to treatment is 
dependent on the type of extender used.  SKMG and REV may benefit from the inclusion 
of L-carnitine and pyruvate while INRA seems to be optimized without the inclusion of 
these treatments. 
Although a larger sample size would likely have led to an increased production of 
statistical significance across individual time points, the general trends in mean values 
show that the addition of L-carnitine and pyruvate may improve multiple viability and 
motility characteristics of equine spermatozoa.   
With all times included, the significance of L-carnitine and pyruvate treatment is 
strongly apparent (see p-value tables in RESULTS section).  The significance of extender 
is likewise strongly apparent.  The addition of L-carnitine and pyruvate in diluents of 
extended equine semen may significantly improve multiple factors of spermatozoa 
survival analysis.  The conclusion can be made that not all commercially available semen 
extenders are equal.  INRA 96 consistently proved to be the best extender of the ones 
used in the trial (Tables 7 and 15) and often times only benefitted slightly from the 
addition of L-carnitine and pyruvate treatment whereas SKMG and Revolution extenders 
were inferior but improved drastically in the presence of L-carnitine/pyruvate.   
Applying this knowledge may lead to an increased fertilizing capacity of a sample 
of equine semen.  Increasing the level of fertility for the stallion will ultimately result in 
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an increased conception rate for the mares. Increased conception rates save the mare 
owner money by reducing the amount of attention due to missed cycles (ultrasounds, 
veterinarian checks, breeding farm fees, etc.).  
All in all, stallions (specifically performance horse stallions) have been selected 
for athletic ability, conformation and trainability and by default their reproductive 
efficiency has gone by the wayside.   More studies are necessary to say that L-carnitine 
and pyruvate inclusion are absolutely beneficial to equine semen; however, this research 
shows that there is strong evidence to support the use of these treatments in semen 
extenders to improve the reproductive capability of the stallion by enhancing the motility 
and viability characteristics of collected semen. 
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